TAPI has advanced health through innovation and dedication, driving pharmaceutical progress with high-quality generics and pioneering solutions. With almost nine decades of experience in APIs, the company offers one of the industry’s most comprehensive API portfolios and customised CDMO services. Its global footprint spans more than 100 countries, supported by 13 manufacturing and R&D sites and a workforce of approximately 4,100 employees. TAPI places active pharmaceutical ingredients at its core, emphasising quality, compliance and technological advancement, while integrating Environmental, Social and Governance (ESG) principles into all operations and striving to reduce the environmental footprint of its manufacturing.

Key Products and Services

• Supply of high-quality APIs (350+ products developed and delivered globally)
• Custom CDMO services including novel technology platforms and full process support
• Advanced fermentation, enzymatic and small-molecule manufacturing capabilities
• Flexible tech-transfer and manufacturing scale-up support through global facility network
• Sustainability-driven manufacturing practices and ESG-compliant production systems

TAPI combines long-standing manufacturing experience, broad global reach and advanced technology platforms to meet the evolving needs of the pharmaceutical industry. As it continues to support both generics and custom supply chains, the company positions itself as a partner of choice for clients seeking high-quality API sourcing, contract manufacturing expertise and scalable services across geographies and modalities.